Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: RPH Pharmaceuticals AB, Box 603, 101 32 Stockholm, Sweden
Neo-Cytamen 1000 micrograms/ml solution for injection.
Hydroxocobalamin 1000 micrograms/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. |
Hydroxocobalamin chloride 1.027mg equivalent to 1.0 mg Hydroxocobalamin.
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Vitamin B12a |
Hydroxocobalamin is a cyanide antidote. Its action in the treatment of cyanide poisoning is based on its ability to bind cyanide ions. Each hydroxocobalamin molecule can bind one cyanide ion by substituting it for the hydroxo ligand linked to the trivalent cobalt ion, to form cyanocobalamin, which is then excreted in the urine. |
| List of Excipients |
|---|
|
Sodium chloride |
1ml clear, one-point cut (OPC) glass Type 1 Ph Eur ampoules packed in cartons of 5 ampoules.
RPH Pharmaceuticals AB, Box 603, 101 32 Stockholm, Sweden
PL36301/0011
14/10/1992 / 21/01/2004
| Drug | Countries | |
|---|---|---|
| NEO-CYTAMEN | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
